Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $549.2M | $638.1M | $739.1M | $922.6M | $1,024.0M | $1,031.6M | $1,103.4M | $1,218.7M | $1,293.3M | $1,377.1M | $1,485.8M | $1,601.9M | $1,775.4M | $1,969.1M | $2,213.2M | $2,406.9M | $2,706.7M | $3,215.4M | $3,367.3M | $3,661.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, IDEXX Laboratories, Inc.'s last 12-month Revenue is $3,897.5M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, IDEXX Laboratories, Inc.'s Revenue growth was 6.5%. The average annual Revenue growth rates for IDEXX Laboratories, Inc. have been 8.6% over the past three years, 10.1% over the past five years.
Over the last year, IDEXX Laboratories, Inc.'s Revenue growth was 6.5%, which is higher than industry growth of 0.3%. It indicates that IDEXX Laboratories, Inc.'s Revenue growth is Good.